儿童全身和局部氟喹诺酮类药物的使用.pdf

FROM THE AMERICAN ACADEMY OF PEDIATRICSPEDIATRICS Volume 138 , number 5 , November 2016 :e 20162706 The Use of Systemic and Topical Fluoroquinolones Mary Anne Jackson, MD, FAAP, Gordon E. Schutze, MD, FAAP, COMMITTEE ON INFECTIOUS DISEASES This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have fi led confl ict of interest statements with the American Academy of Pediatrics. Any confl icts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication. Clinical reports from the American Academy of Pediatrics benefi t from expertise and resources of liaisons and internal (AAP) and external reviewers. However, clinical reports from the American Academy of Pediatrics may not refl ect the views of the liaisons or the organizations or government agencies that they represent. The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate. All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffi rmed, revised, or retired at or before that time. DOI: 10.1542/peds.2016-2706 PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275). Copyright © 2016 by the American Academy of Pediatrics FINANCIAL DISCLOSURE: have no fi nancial relationships relevant to this article to disclose. FUNDING: No external funding. POTENTIAL CONFLICT OF INTEREST: indicated they have no potential confl icts of interest to disclose. abstractAppropriate prescribing practices for fl uoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identifi ed, and the toxicity p